Binex Co

Binex Co OCF Margin

The Operating Cash Flow Margin of Binex Co (053030.KQ) as of Oct 27, 2026 is -13.81 %. In the previous year, Operating Cash Flow Margin was -7.25 % — a change of 90.56% (lower).

OCF Margin

-13.81 %

YoY

90.56%

Last updated:

Operating Cash Flow Margin of Binex Co is 2025 -13.81 % . Operating Cash Flow Margin of Binex Co was 2024 -7.25 % . It decreases by 90.56% lower compared to the previous year.

The Binex Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
13.03 KRW
Jan 1, 2019
8.61 KRW
Jan 1, 2020
14.98 KRW
Jan 1, 2021
20.89 KRW
Jan 1, 2022
10.89 KRW
Jan 1, 2023
2.44 KRW
Jan 1, 2024
-7.25 KRW
Jan 1, 2025
-13.81 KRW
The Binex Co OCF Margin history
YEAROCF MarginYoY
-13.81 %+90.56%
-7.25 %-397.03%
2.44 %-77.59%
10.89 %-47.86%
20.89 %+39.43%
14.98 %+73.97%
8.61 %-33.94%
13.03 %+25.00%
10.43 %+122.13%
4.69 %-169.46%
-6.76 %+572.20%
-1.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Binex Co Stock analysis

What does Binex Co do? Binex Co Ltd generates revenue through the manufacturing and sale of pharmaceutical products including digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal tract regulators, antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, and various ointments and creams. The company also produces bio medicines and raw materials. Binex Co Ltd distributes its products domestically within Busan and to overseas markets, targeting healthcare providers, pharmacies, and hospitals that purchase pharmaceuticals for patient care and treatment. The firm's product portfolio covers a wide range of therapeutic areas, including gastrointestinal health, cardiovascular support, pain management, respiratory care, and chronic disease management. By offering both branded and generic pharmaceutical solutions, Binex Co Ltd serves diverse customer segments across the domestic and international pharmaceutical markets, leveraging its manufacturing capabilities to meet regional healthcare demands. Binex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Binex Co stock

Operating Cash Flow Margin of Binex Co is -13.81 % in 2025.

Operating Cash Flow Margin of Binex Co changed from -7.25 % to -13.81 %, representing a 90.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Binex Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Binex Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Binex Co

All Key Metrics — Binex Co